ConductScience.org, home

Paper4584690

Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings.

Grunberg E and 1 other. Annu Rev Microbiol, 1973. Cited by 87 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings. Papers, record 4584690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4584690

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings.
PubMed
Journal
Annu Rev Microbiol
PubMed
Year
1973
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
3.85
iCite
Revised in PubMed
2000-12-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grunberg EE
2Titsworth EHE H

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heterocyclic CompoundsMajor topic
Nitro CompoundsMajor topic
NitrofuransMajor topic
NitroimidazolesMajor topic
ThiazolesMajor topic
Bacteria
Bacterial Infections
Helminthiasis
Mycoses
Protozoan Infections
Schistosomiasis
Species Specificity
Virus Diseases

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
365696574-Hydroxy-3-nitro-1,4-dihydrotriazolo[5,1-c][1,2,4]triazines: synthesis, antiviral activity, and electrochemical characteristics.Russ Chem Bull2022https://conductscience.org/library/papers/36569657PubMed
34443674Redox Conversions of 5-Methyl-6-nitro-7-oxo-4,7-dihydro-1,2,4triazolo[1,5-a]pyrimidinide L-Arginine Monohydrate as a Promising Antiviral Drug.Molecules2021https://conductscience.org/library/papers/34443674PubMed
24776300Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects.Trends Parasitol2014https://conductscience.org/library/papers/24776300PubMed
24165190Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugs.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24165190PubMed
23946481An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs.J Biol Chem2013https://conductscience.org/library/papers/23946481PubMed
20679506Trypanocidal activity of aziridinyl nitrobenzamide prodrugs.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20679506PubMed
20028822Exploiting the drug-activating properties of a novel trypanosomal nitroreductase.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20028822PubMed
18367671A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18367671PubMed
6721462Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6721462PubMed
6714854Antimicrobial effects of esters and amides of 3-(5-nitro-2-furyl)acrylic acid.Folia Microbiol (Praha)1984https://conductscience.org/library/papers/6714854PubMed
4451351Susceptibility of an insect Leptomonas and Crithidia fasciculata to several established antitrypanosomatid agents.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4451351PubMed
3800344Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3800344PubMed
2998746Structure-activity relationships in the free-radical metabolism of xenobiotics.Environ Health Perspect1985https://conductscience.org/library/papers/2998746PubMed
2729935Antibacterial activities of the antiparasitic drugs nifurtimox and benznidazole.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2729935PubMed
1083712Uptake of metronidazole and its effect on viability in trichomonads and Entamoeba invadens under anaerobic and aerobic conditions.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1083712PubMed
810079Antibacterial activity of nitropyrroles, nitrothiphenes, and aminothiophenes in vitro.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/810079PubMed
791102Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/791102PubMed
646342Use of high-pressure liquid chromatography to determine plasma levels of metronidazole and metabolites after intravenous administration.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/646342PubMed
626487Absence of strand breaks in deoxyribonucleic acid treated with metronidazole.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/626487PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4584690

GET https://conductscience.org/api/papers/v1/4584690/authors